Evaluation and determinants of asthma control among adult patients with asthma attending the Johannesburg academic respiratory clinics: A cross-sectional study
Article Sidebar
Main Article Content
Abstract
Background. The prevalence of asthma in South Africa is among the highest in Africa, but little research has been done regarding levels of asthma control and associated determinants.
Objectives. To explore level of asthma control and perceived risk factors associated with poor control in adult patients with asthma attending respiratory clinics at three major hospitals in Johannesburg.
Methods. This was a quantitative, descriptive, cross-sectional study of all adult patients attending the clinics. Participants were given a three-section self-reporting survey, consisting of a demographic section, an Asthma Control Test (ACT) questionnaire, and an eight-item Morisky Medication Adherence Scale (MMAS-8) questionnaire.
Results. The prevalence of poor asthma control based on participants’ ACT scores in this study was 71.3%. A significant linear regression was identified between the ACT and MMAS-8 scores in the uncontrolled asthma group. Significant associations between asthma control and the sociodemographic factors age, body mass index ≥25 and previous hospitalisation for exacerbation were found. No such associations existed for gender or level of education. In evaluating comorbidities, no significant association was found for hypertension, gastro-oesophageal reflux disease, sinusitis or diabetes mellitus. Of the patients, 89.3% used short-acting beta-agonists and 93.3% inhaled corticosteroids (ICSs); 58.7% were on combined long-acting beta-agonists and ICSs.
Conclusion. Asthma control in the study setting was poor. There was also an interesting inverse relationship between control and therapy adherence. Further research is needed to better understand the issues surrounding asthma control and to lay the groundwork for policies to benefit asthma patients in the future.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Adeloye D, Chan KY, Rudan I, Campbell H. An estimate of asthma prevalence in Africa: A systematic analysis. Croat Med J 2013;54(6):519-531. https://doi. org/10.3325/cmj.2013.54.519
2. Global Asthma Network. The Global Asthma Report 2018. Auckland, New Zealand: Global Asthma Network, 2018. https://globalasthmareport.org/2018/resources/ Global_Asthma_Report_2018.pdf (acessed 10 November 2022).
3. Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O’Byrne PM. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J 2019;54(2):1900598. https://doi.org/10.1183/13993003.00598-2019
4. Demoly P, Paggiaro P, Plaza V, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009;18(112):105-112. https://doi.org/10.1183/09059180.00001209
5. Kabengele OB, Kayembe J, Kayembe P, et al. Factors associated with uncontrolled asthma in adult asthmatics in Kinshasa, Democratic Republic of Congo. PLoS ONE 2019;14(4):e0215530. https://doi.org/10.1371/journal.pone.0215530
6. MarcusP,ReneeA,EkinsS,etal.Aretrospectiverandomizedstudyofasthmacontrol in the US: Results of the CHARIOT study. Curr Med Res Opin 2008;24(12):3443- 3452. https://doi.org/10.1185/03007990802557880
7. Rabe KF, Adachi M, Lai C, et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114(1):40-47. https://doi.org/10.1016/j.jaci.2004.04.042
8. Olajide-Ibiejugba AO, Nkosi V, Rathogwa-Takalani F, et al. Asthma control among adolescents in the inner provinces of South Africa: Perception v. reality. S Afr J Child Health 2023;17(1):1-3. https://doi.org/10.7196/SAJCH.2023.v17i1.1958
9. BaardC,Franckling-SmithZ,MunroJ,WorkmanL,ZarHJ.AsthmainSouthAfrican adolescents: A time trend and risk factor analysis over two decades. ERS Open Res 2021;7(2):00576-2020. https://doi.org/10.1183/23120541.00576-2020
10. Zeru T, Engidawork E, Berha A. Assessment of asthma control and quality of life among asthmatic patients attending Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia. Pulm Med 2020;2020:5389780. https://doi. org/10.1155/2020/5389780
11. BinSaeed AA. Asthma control among adults in Saudi Arabia: Study of determinants. Saudi Med J 2015;36(5):599-604. https://doi.org/10.15537/smj.2015.5.10929
12. Ghanname I, Chaker I, Hassani C, et al. Factors associated with asthma control: MOSAR study (Multicenter Observational Study of Asthma in Rabat-Morocco). BMC Pulm Med 2018;18(1):61. https://doi.org/10.1186/s12890-018-0624-6
13. Ngahane B, Pefura-Yone E, Mama M, et al. Evaluation of factors affecting adherence to asthma controller therapy in chest clinics in sub-Saharan African setting: A cross- sectional study. Afr Health Sci 2016;16(1):194-200. https://doi.org/10.4314/ahs. v16i1.26
14. Alzahrani YA, Becker EA. Asthma control assessment tools. Respir Care 2013;61(1):106-116. https://doi.org/10.4187/respcare.04341
15. Jia CE, Zhang H, Lv Y, et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis. J Allergy Clin Immunol 2013;131(3):695-703. https://doi.org/10.1016/j.jaci.2012.08.023
16. Janežič A, Locatelli I, Kos M. Criterion validity of 8-item Morisky Medication Adherence Scale in patients with asthma. PLoS ONE 2017;12(11):e0187835. https:// doi.org/10.1371/journal.pone.0187835
17. Demoly P, Paggiaro P, Plaza V, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009;18(112):105-112. https://doi.org/10.1183/09059180.00001209
18. Yan B, Meng S, Ren J, et al. Asthma control and severe exacerbations in patients with moderate or severe asthma in Jilin Province, China: A multicenter cross-sectional survey. BMC Pulm Med 2016;16(1):130. https://doi.org/10.1186/s12890-016-0292-3
19. Soriano J, Rabe K, Vermeire P. Predictors of poor asthma control in European adults. J Asthma 2003;40(7):803-813. https://doi.org/10.1081/jas-120023572
20. TalrejaN,BaptistA.Effectofageonasthmacontrol:ResultsfromtheNationalAsthma Survey. Ann Allergy Asthma Immunol 2011;106(1):24-29. https://doi.org/10.1016/j. anai.2010.10.017
21. Lavoie K, Bacon S, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006;100(4):648-657. https://doi.org/10.1016/j.rmed.2005.08.001
22. Christiansen SC, Schatz M, Yang SJ, Ngor E, Chen W, Zuraw BL. Hypertension and asthma: A comorbid relationship. J Allergy Clin Immunol Pract 2016;4(1):76-81. https://doi.org/10.1016/j.jaip.2015.07.009
23. Rogliani P, Laitano R, Ora J, Beasley R, Calzetta L. Strength of association between comorbidities and asthma: A meta-analysis. Eur Respir Rev 2023;32(167):220202. https://doi.org/10.1183/16000617.0202-2022
24. Chiu KC, Boonsawat W, Cho SH, et al. Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia. J Asthma 2014;51(6):652-659. https://doi.org/10.3109/02770903.2014.898772
25. Young HN, Larson TL, Cox ED, Moreno MA, Thorpe JM, MacKinnon NJ. The active patient role and asthma outcomes in an underserved rural community. J Rural Health 2014;30(2):121-127. https://doi.org/10.1111/jrh.12031
26. Engelkes M, Janssens H, de Jongste J, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: A systematic review. Eur Respir J 2015;45(2):396-407. https://doi.org/10.1183/09031936.00075614
27. Boland MR, van Boven JF, Kruis AL, et al. Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence. Respir Med 2016;110:34-45. https://doi.org/10.1016/j.rmed.2015.11.008
28. Nwaru BI, Ekstrom M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short- acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme. Eur Respir J 2020;55(4):1901872. https://doi.org/10.1183/13993003.01872-2019
29. National Institute for Communicable Diseases, South Africa. Weekly respiratory pathogens report: Week 48 of 2023. Johannesburg: NICD, 2023. https://www.nicd. ac.za/wp-content/uploads/2023/12/Weekly-RPSR-FluRSVSARSCoV2Pertussis- Week-48-Final.pdf (accessed 1 July 2024).